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SUMMARY

In bacteria, AAA+ proteases such as Lon and ClpXP degrade substrates with exquisite specificity. These machines capture the energy of ATP hydrolysis to power unfolding and degradation of target substrates. Here,
we show that a mutation in the ATP binding site of ClpX shifts protease specificity to promote degradation of
normally Lon-restricted substrates. However, this ClpX mutant is worse at degrading ClpXP targets, suggesting an optimal balance in substrate preference for a given protease that is easy to alter. In vitro, wild-type
ClpXP also degrades Lon-restricted substrates more readily when ATP levels are reduced, similar to the
shifted specificity of mutant ClpXP, which has altered ATP hydrolysis kinetics. Based on these results, we
suggest that the rates of ATP hydrolysis not only power substrate unfolding and degradation, but also
tune protease specificity. We consider various models for this effect based on emerging structures of
AAA+ machines showing conformationally distinct states.

INTRODUCTION
Energy-dependent protein degradation regulates normal growth
and stress responses in all cells. In bacteria, regulated proteolysis is carried out by several energy-dependent AAA+ (ATPases
associated with cellular activities) proteases, which include
Lon, ClpXP, ClpAP, HslUV, and FtsH (Gur et al., 2011; Mahmoud
and Chien, 2018). These proteases share a similar general architecture containing an unfoldase domain and a non-specific
peptidase (Sauer and Baker, 2011). The two domains can be encoded on a single polypeptide, such as in the case of Lon and
FtsH, or they can be encoded by separate proteins, an
ATPase, such as ClpX, and a peptidase, such as ClpP (Baker
and Sauer, 2012; Langklotz et al., 2012; Lee and Suzuki, 2008).
Using the power of adenosine triphosphate (ATP) hydrolysis,
the unfoldase recognizes, unfolds, and translocates substrates
into the sequestered peptidase chamber to be degraded.
Because they are critical for maintaining proteostasis, the loss
of these proteases results in defects in growth, cell cycle progression, stress responses, and pathogenesis (Breidenstein
et al., 2012; Howard-Flanders et al., 1964; Jenal and Fuchs,
1998; Rogers et al., 2016).
Despite the similarities in both architecture and mechanism,
these proteases generally have distinct niches of substrate preference. For example, in Caulobacter crescentus, Lon is the principal protease for degradation of the replication initiator DnaA
(Jonas et al., 2013), the methyltransferase CcrM (Wright et al.,
1996), and the transcriptional regulator SciP (Gora et al., 2013).
By contrast, the ClpXP protease degrades cell-cycle factors
like CtrA and TacA during cell cycle progression through an
adaptor hierarchy (Joshi et al., 2015). Lon is also responsible
for misfolded protein degradation (Goldberg, 1972; Gur and
Sauer, 2008; Jonas et al., 2013). However, although a handful

of target substrates for these AAA+ proteases have been identified, it remains unclear how proteases are able to discriminate
among protein targets and recognize distinct substrates for irreversible degradation.
In this work, we find that a variant of ClpX (clpX*) can compensate for the absence of the Lon protease. The expression of clpX*
suppresses defects in motility, growth, filamentation, and sensitivity to stress normally seen in a Dlon strain. In addition to this
phenotypic rescue, the degradation of normal Lon substrates
is restored in vivo and in vitro by ClpX*P. This increased ability
to degrade noncanonical substrates comes at the cost of
reduced degradation of ClpXP-specific substrates, resulting in
fitness defects in otherwise wild-type strains expressing the
clpX* allele. Further mechanistic characterization shows that
ClpX* has decreased catalytic efficiency for ATP hydrolysis, suggesting a connection between ATP use and substrate specificity.
Consistent with this, limiting ATP for wild-type ClpXP shifts substrate preferences similar to that of ClpX*P. Limited proteolysis,
differential scanning fluorimetry (DSF), and hydrogen-deuterium
exchange mass spectrometry (HDX-MS) show that the ClpX unfoldase adopts distinct conformations under these ATP limiting
or saturating conditions. Taken together, our work demonstrates
that ATP-dependent dynamics between conformational states
are important for substrate recognition by AAA+ unfoldases.
RESULTS
A suppressor screen identifies a clpX mutant which
rescues Dlon
We reasoned that a suppressor screen would allow us to identify
Lon-related interactions and used a transposon library to identify
mutations that restore motility to a Dlon strain. We isolated a high
motility mutant with a transposon insertion in CCNA_00264;
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however, transduction experiments revealed that this transposon alone was not able to rescue motility (Figure S1A). Sequencing the genome of the suppressor strain showed a point mutation in clpX, which resulted in a single amino acid change from
glycine 178 to alanine (clpX*). This glycine is highly conserved
among ClpX homologs and immediately adjacent to the Walker
B motif (Figure S1C). By generating the clpX* allele in a Dlon
background, we found that clpX* on its own partially restores
motility (Figure 1A).
We were intrigued that a single mutation in clpX could restore
motility to cells lacking Lon and chose to further characterize this
strain. Cells lacking Lon show growth defects that exhibit as an
extended lag phase and reduced cell mass accumulation in stationary phase (Figure 1A). The clpX* allele rescues the mass
accumulation defect, but not the extended lag (Figure 1A).
Dlon strains also have significant morphological deficiencies,
including elongated cell length and longer stalks, external polar
organelles characteristic of Caulobacter. We found that the
clpX* mutant restored the cell length of Dlon strains to near
wild-type levels (Figures 1B and 1C). However, stalks remained
elongated in the Dlon clpX* strain (Figures 1B and 1C).
We next wondered if, in addition to suppression of Dlon
morphological and growth defects, sensitivity to certain
stressors would be suppressed by this clpX* allele. One of the
originally described phenotypes for Escherichia coli lon mutants
is DNA damage sensitivity (Mizusawa and Gottesman, 1983;
Witkin, 1946) and Caulobacter Dlon strains are also highly sensitive to various DNA damaging agents (Zeinert et al., 2018),
including mitomycin C (MMC) (Figure 1C). We found that Dlon
clpX* was 100-fold more resistant to MMC than Dlon alone
(Figure 1C).
As mentioned previously, Lon is the major protease responsible for the degradation of the replication initiator DnaA and
Dlon strains accumulate excess chromosome content (Jonas
et al., 2013; Wright et al., 1996). Like the morphological abnormalities, over-replication is suppressed in the Dlon clpX* strain,
which shows similar chromosome content as wild-type cells
(Figures 1D and S1D). To determine if this rescue extended to
a systems-level correction, we compared RNA sequencing
(RNA-seq) profiles of wild-type, Dlon, and Dlon clpX* strains.
As expected, many genes (435) are differentially expressed
upon loss of Lon (Figure 1E; Data S1), while the Dlon clpX* strain
shows fewer differences (119), with only 85 genes overlapping
between these sets. Finally, we assayed the overall physiological
consequence of ClpX* using competitive fitness in mixed cultures. We grew cultures of Dlon or the Dlon clpX* strain together
with Dlon strains constitutively expressing the Venus fluorescent
protein (Persat et al., 2014). We found that Dlon clpX* cells were
more fit than Dlon cells (Figure S1E). Our interpretation is that
expression of clpX* on a Dlon background largely shifts the phenotypes and transcriptional landscape to more wild-type
profiles.
ClpX* restores degradation of Lon substrates in vivo
Because cells lacking Lon would accumulate normally degraded
substrates, we hypothesized that the rescue we observed in the
Dlon clpX* strain was likely owing to the lower levels of Lon substrates, such as DnaA, CcrM, and SciP (Figure 2A) (Wright et al.,
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1996; Gora et al., 2013; Jonas et al., 2013). As expected, in unsynchronized cells, DnaA and CcrM levels are higher in the
Dlon strain than in wild type (Figure 2B). Similarly, SciP levels
are higher in Dlon swarmer cells in comparison with wild type
(Figure 2D). Interestingly, levels of DnaA and SciP are restored
to wild-type levels in the Dlon clpX* strain; however, CcrM remained at higher levels (Figure 2B). The lower levels of DnaA
likely explain the rescue of replication defects and an enrichment
analysis of the RNA-seq results shows that the SciP-controlled
regulon and cell cycle gene expression are largely restored in
the Dlon clpX* strain (Figure S2). We reasoned that the expression of clpX* rescues normal growth and critical stress responses in a Dlon strain through restoring wild-type levels of
key proteins.
Next, we explored the mechanism by which a mutation in ClpX
restores steady-state levels of DnaA and SciP. Because DnaA
and SciP are controlled by proteolysis, we suspected that protein turnover may be affected. As expected, DnaA is largely stabilized in Dlon strains (Figure 2C; Jonas, et al., 2013); however,
we found that DnaA degradation was restored in the Dlon
clpX* strain, with a half-life similar to that of wild type (Figure 2D).
SciP protein dynamics and cell cycle phase specific levels were
also restored in Dlon clpX* cells (Figure 2D). By contrast, CcrM
degradation was still solely dependent on Lon, even when
clpX* was present, in both unsynchronized cells (Figure 2C)
and during cell cycle progression (Figure S2D).
We considered that changes in protein turnover could be
either due to a gain of function in the clpX* mutant or by indirect
cellular effects associated with a loss of function in clpX. To test
this, we created a merodiploid Dlon strain expressing a second
copy of clpX or clpX* under control of the native promoter along
with a normal chromosomal copy of clpX. We reasoned that, if
the effect was direct, then expression of clpX* would be sufficient to restore DnaA degradation. If the effect was indirect,
then DnaA would remain stable. Consistent with a gain-of-function phenotype for the clpX* allele, we found that DnaA turnover
increased upon expression of clpX* but not wild-type clpX (Figure 2E). Similarly, the phenotypic rescue we observed in the
Dlon clpX* strain was also due to a gain-of-function activity as
the merodiploid strain expressing clpX* suppressed Dlon defects, such as growth, motility, and genotoxic stress tolerance
(Figures S2E–S2G). Because ClpXP is a AAA+ protease, we hypothesized that ClpX*P (the protease complex of the variant
ClpX* with wild-type ClpP) was now able to recognize and
degrade substrates normally degraded by Lon.
ClpX*P directly degrades Lon substrates in vitro
As a direct test of our hypothesis, we purified the ClpX* variant
and reconstituted degradation in vitro. Upon initial characterization of purified ClpX*, we found that it formed an active ATPase,
but hydrolyzed ATP three times faster than wild type (Figure S3A).
Consistent with the fact that Lon is the principal protease for
DnaA degradation (Jonas et al., 2013; Liu et al., 2016), we found
that wild-type ClpXP poorly degraded DnaA in vitro (Figure 3A).
However, purified ClpX*P could degrade DnaA four times faster
than ClpXP (Figure 3A). Similarly, SciP was degraded three times
faster by ClpX*P in comparison with ClpXP (Figure 3A). Finally, as
predicted from our in vivo results, CcrM was not degraded by
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Figure 1. clpX* mutant suppresses Dlon phenotypes
(A) Growth curves of wild-type (wt), Dlon, and Dlon clpX* cells grown in PYE. Biological triplicate experiments are shown. Error bars represent 95% confidence
interval. Inset shows motility assays as measured by growth in 0.3% PYE agar.
(B) Representative phase-contrast microscopy images of wt, Dlon, and Dlon clpX* cells grown in PYE during exponential phase. Quantification of cell length and
stalk length for three biological replicates of n = 100 cells. Error bars represent the standard deviation.
(C) Serial dilution assays comparing colony formation of strains in PYE and PYE supplemented with MMC. Spots are plated 10-fold dilutions of exponentially
growing cells from left to right.
(D) Flow cytometry profiles showing chromosome content of indicated strains after 3-hour treatment with rifampicin. Cells were stained with SYTOX Green to
measure DNA content. The fluorescent intensities corresponding with one chromosome (1) and two chromosomes (2) are indicated. Experiment was performed
two times. Representative data from one of the biological replicates is shown here.
(E) Venn diagram summarizing the number of differentially expressed genes with a false discovery rate (FDR) cutoff less than 0.01 from RNA-seq performed with
stationary phase cells. Venn diagram created by BioVenn (Hulsen, de Vlieg and Alkema, 2008). See also Figure S1 and Data S1.

either ClpX*P or ClpXP (Figures 3A and S3B), but was well
degraded by Lon (Figure S3B). Thus, ClpX* seems to have an
expanded substrate profile, which includes some Lon substrates, but others, such as CcrM, remain exclusive to Lon.

Lon recognizes exposed hydrophobic amino acids (Gur and
Sauer, 2008) and is best known as a quality control protease
that eliminates mis/unfolded proteins (Goff et al., 1984). Given
its altered specificity, we considered whether ClpX* could now

Cell Reports 40, 111405, September 20, 2022 3

ll
OPEN ACCESS

Article

Figure 2. clpX* mutant restores levels of Lon substrates through degradation
(A) Lon degrades DnaA, SciP, and CcrM in C. crescentus (Wright et al., 1996; Gora et al., 2013; Jonas et al., 2013).
(B) Western blot showing DnaA and CcrM levels in wt, Dlon, and Dlon clpX* cells. Lysates from an equal number of exponential phase cells were probed with antiDnaA or anti-CcrM antibody. ClpP was used as a loading control. A representative image and quantifications of triplicate experiments are shown. Line represents
the mean.
(C) Antibiotic shutoff assays to monitor DnaA and CcrM stabilities in wt, Dlon, and Dlon clpX* cells. Chloramphenicol was added to stop synthesis and lysates from
samples at the indicated time points were used for western blot analysis. Quantifications of triplicate experiments with substrate shown relative to ClpP control
levels are shown to the right. Error bars represent the standard deviation.
(D) Western blot showing SciP levels in synchronized populations of wt, Dlon, and Dlon clpX* cells. Swarmer cells were isolated using a density gradient and an
equal number of cells were released into fresh PYE medium. Samples were withdrawn at the indicated time points and probed with anti-SciP.
(E) DnaA stability is measured in Dlon strains expressing an extra copy of wild-type clpX or clpX*. Experiment was performed four times. Representative data from
one of the biological replicates is shown here. Quantifications of experiments shown to the right. Error bars represent the standard deviation. See also Figure S2.

recognize these substrates. Casein is commonly used as an
in vitro model substrate for misfolded or unfolded proteins. Lon
robustly degrades fluorescently labeled casein, whereas wildtype ClpXP poorly degrades this substrate (Figure 3B). Intriguingly, ClpX*P degrades fluorescence isothiocyate (FITC)-casein
more than twice as fast as ClpXP (Figures 3B and S3C). Similar
to casein, ClpX*P degrades another unfolded Lon substrate, a
chemically denatured domain of titin tagged with the hydrophobic sequence b20 (Gur and Sauer, 2008), better than wild-type
ClpXP (Figure S3D).
Because cells lacking Lon are sensitive to proteotoxic stresses
that create misfolded proteins and because ClpX*P is better at
degrading misfolded or unfolded substrates than wild-type
ClpXP, we wondered if the Dlon clpX* strain would be more resis4 Cell Reports 40, 111405, September 20, 2022

tant to stressors that induce cellular protein misfolding. Indeed,
the presence of the clpX* allele protected Dlon cells from
hypersensitivity to the proteotoxic amino acid L-canavanine (Figure 3B). We conclude that ClpX* has an altered substrate preference, which includes DnaA, SciP, and unfolded proteins, whose
degradation are normally governed by the Lon protease.
ClpX*P is deficient in degradation of native ClpXP
substrates
Mutations in ClpX that improve recognition of some substrates
can have negative consequences on others (Farrell et al.,
2007). Green fluorescent protein (GFP)-ssrA is a well characterized ClpXP substrate that is directly bound by the pore loops of
ClpX (Fei et al., 2020; Gottesman et al., 1998). We purified GFP
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Figure 3. ClpX*P degrades some Lon substrates faster than ClpXP in vitro
(A) In vitro degradation of DnaA, SciP, or CcrM. Assays were performed with 0.1 mM ClpX6 or ClpX6*, and 0.2 mM ClpP14. Substrate concentrations were 1 mM
DnaA, 5 mM SciP, 0.5 mM CcrM. Quantification of triplicate experiments shown. Error bars represent the standard deviation.
(B) In vitro fluorescence degradation assay of FITC-casein in the presence of ClpXP or ClpX*P or Lon. Degradation assays were performed with 10 mg/mL FITCCasein, 0.1 mM ClpX6 or ClpX6*, and 0.2 mM ClpP14 or 0.1 mM Lon6. Serial dilution assays comparing colony formation of strains in PYE and PYE supplemented
with L-canavanine. Spots are plated 10-fold dilutions of exponentially growing cells from left to right. See also Figure S3.

fused to the Caulobacter ssrA tag (Chien, et al., 2007), determined degradation rates by ClpX*P and ClpXP, and fit these
rates to the Michaelis-Menten equation. We found that ClpX*P
degrades GFP-ssrA more poorly than wild-type ClpXP, principally lowering the turnover rate (Figures 4A and S4A), suggesting
that either ClpX* fails to irreversibly initiate degradation via the
ssrA tag as readily or is unable to translocate the reporter protein
as well as wild-type ClpX.
CtrA is a master regulator in Caulobacter that inhibits replication initiation and regulates the transcription of many cell cycle
genes (Laub et al., 2002; Wortinger et al., 2000). In vivo, CtrA is
degraded during the G1–S transition by ClpXP through the use
of an adaptor hierarchy (Domian et al., 1999; Jenal and Fuchs,
1998; Joshi et al., 2015; Quon et al., 1996); however, in vitro
CtrA can also be directly recognized by ClpXP as its C terminus
resembles the ssrA tag (Chien et al., 2007). Consistent with a
decreased ability to recognize ClpXP substrates, ClpX*P degrades isolated CtrA more poorly than wild type (Figure 4B)
and also shows reduced degradation of a CtrA-derived GFP reporter (Smith et al., 2014) in the presence of the full adaptor
hierarchy (Figure S4B). We conclude that ClpX*P overall has a
diminished ability to recognize and degrade native substrates
normally degraded by ClpXP.
Deficiencies of ClpX* revealed when Lon is present
The prior in vitro data suggest that, rather than just expanding
specificity, this mutation has allowed ClpX*P to degrade Londependent substrates better, but at the cost of degrading

ClpXP-dependent ones. If this is true, while clpX* is beneficial
in a Dlon background, we reasoned that it may be detrimental
to lon+ cells.
To test this hypothesis, we generated an otherwise wild-type
strain with clpX* as its sole copy. We first examined ssrA tag turnover in this strain by using an ssrA derivative that relies on the
SspB adaptor for degradation (eGFP-ssrA[DAS]) (Chowdhury
et al., 2010) so that degradation would be sufficiently slowed
to be visualized by western blotting. Consistent with our in vitro
experiments, we observed stabilization and dramatically higher
levels of eGFP-ssrA (DAS) in the clpX* strain in comparison
with wild type (Figure 4C). We observed reduced CtrA degradation in the clpX* strain, consistent with our in vitro observations (Figure 4C). Finally, DnaA degradation is accelerated in
the clpX* strains compared with wild type, consistent with our
findings that both Lon and ClpX*P are able to degrade DnaA
(Figure 4C).
To assess the overall impact of ClpX* on wild-type cells, we
performed competition assays as described previously using a
wild-type strain constitutively expressing the Venus fluorescent
protein (Persat et al., 2014). We found that, while nonfluorescent
wild-type cells could slightly outcompete the constitutive Venusexpressing cells, the clpX* strain showed a substantial competitive disadvantage (Figure 4D). We also tested for stress
tolerances and found that clpX* strains fail to survive genotoxic
stress as robustly as wild type (Figure 4E). Our conclusion is
that reduced fitness of the wild-type clpX* strain is likely due to
reduced degradation of normal ClpXP substrates (such as
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Figure 4. ClpX* mutant is deficient in degradation of native ClpXP substrates
(A) Michaelis-Menten plot showing the rate of degradation as a function of GFP-ssrA concentration by ClpXP and ClpX*P. The inset displays kinetic parameters.
Assays were performed with 0.1 mM ClpX6 or ClpX*6, 0.2 mM ClpP14, ATP regeneration system, and the indicated concentrations of GFP-ssrA. Data were fitted to
the Michaelis-Menten equation. Triplicate experiments are shown. Error bars represent the standard deviation.
(B) In vitro degradation assay of His-CtrA in the presence of ClpXP or ClpX*P. Degradation assays were performed with 3 mM His-CtrA, 0.1 mM ClpX6 or ClpX*6,
0.2 mM ClpP14, and ATP regeneration system. Quantification of duplicate experiments is shown below. Error bars represent the standard deviation.
(C) In vivo degradation assay showing eGFP-ssrA (DAS), DnaA, and CtrA stability in wild-type (WT) and clpX* cells. The plasmid encoded M2FLAG-eGFP-ssrA
(DAS) construct was induced with the addition of 0.2% xylose. Chloramphenicol was used to inhibit protein synthesis. Samples were withdrawn at the indicated
time points and quenched in SDS lysis buffer. Lysate from an equal number of cells was used for western blot analysis and probed with anti-M2, or anti-CtrA, and
anti-DnaA antibody. Quantification of triplicate experiments is shown below. Error bars represent the standard deviation.
(D) Competition assay with wild-type cells harboring xylX:Plac-venus (constitutive venus expression) and nonfluorescent WT or clpX* strains. exponential phase
cells were mixed 1:1, diluted, and allowed to outgrow for 12 doublings. Quantification of triplicate experiments is shown below. Error bars represent the standard
deviation.
(E) Serial dilution assays comparing colony formation of WT and clpX* cells in PYE and PYE supplemented with MMC. Spots are plated 10-fold dilutions of
exponentially growing cells from left to right. See also Figure S4.
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CtrA) and prolific degradation of normal Lon substrates (such as
DnaA) that together decrease overall fitness. Collectively, this
supports our understanding that AAA+ proteases have been
optimized for specific priorities in a cell—expansion of their substrate profile, as seen with clpX*, can compensate for loss of
other proteases, but at the cost of their ability to recognize their
normal substrates.
Limiting ATP alters wild-type ClpXP substrate
specificity
To understand how this mutation in ClpX leads to enhanced
degradation of certain substrates, we further characterized the
ATPase activity of ClpX*. While ClpX* hydrolyzes ATP three times
faster than wild-type ClpX at saturating ATP concentrations
(Figure S4A), Michaelis-Menten experiments showed that the
KM increases by five to six times and the kcat for ATP hydrolysis
increases by approximately three times (Figure 5A). While KM
does depend on kcat, the magnitude of KM increase given the
change in kcat suggests that there may also be deficiencies in
nucleotide binding of ClpX*. To test this, we used ATP to
compete off mant-adenosine triphosphate (ADP), a fluorescent
ADP analog and we observed at least a three-fold increase in
the half maximal inhibitory concentration (IC50) for ClpX*, suggesting that it binds ATP worse than wild-type ClpX (Figure S5A).
To make sure that the observed difference in the IC50 between
ClpX and ClpX* was due to changes in nucleotide binding and
not because of the hydrolysis of ATP in the assay, we also
competed mant-ADP using ATPgS and assayed changes using
fluorescence polarization. Consistent with the ATP titration
described above, we calculated a higher IC50 for ATPgS for
ClpX* (Figure S5B).
As seen previously, degradation of GFP-ssrA by ClpXP is precipitously lost below a minimum threshold of ATP (Martin et al.,
2008a), with the ClpX*P threshold being higher than that of
wild type, consistent with the higher KM for ATP described above
(Figure S5C). For ClpX*P, casein degradation decreased monotonically as ATP concentration was lowered (Figure 5B). In striking contrast, we found that, for wild-type ClpXP, casein degradation was increased at intermediate nucleotide concentrations
compared with saturating ATP (Figure 5B). Kinetic analyses
show that at these lower ATP concentrations ClpXP degrades
casein with a lower KM and a similar Vmax compared with saturating ATP conditions (Figure 5C). Since KM = KD + kcat/kon, the
lower KM suggests that, at a minimum, casein must bind better
to ClpX at these concentrations.
These results suggest that ClpX specificity depends on the
ATP concentration and rates of hydrolysis, with lower levels of
ATP facilitating ClpX recognition of some substrates better
than at saturating ATP concentrations. Similar to casein, we
saw this same dependence in vitro with the Lon substrates
DnaA and SciP (Figures 5D and S5D). To test this effect in vivo,
we monitored degradation of DnaA during starvation, which
should decrease cellular ATP levels, using a Dlon DclpA strain
to eliminate any non-ClpX dependent degradation (Liu et al.,
2016). We verified that glucose starvation results in DnaA degradation in wild-type cells (Gorbatyuk and Marczynski, 2005; Figure 5E) and showed that starving Dlon DclpA also markedly
increased DnaA degradation (Figure 5E). During this starvation,

there was also a decrease in bulk ATP levels (Figure S5E),
although we note that the magnitude of the decrease is less
than the changes we observe in vitro that alter ClpX specificity.
We conclude that ClpX preference depends on ATP binding or
hydrolysis, with its specificity expanded under limiting ATP
conditions.
We considered whether conformational changes in ClpX might
explain the altered specificity of wild-type ClpX at low ATP or the
changes associated with ClpX*. Using limited proteolysis to
probe conformational differences, we found that ClpX at low
ATP was more protease accessible than at high ATP (Figure 6A).
Similarly, protease accessibility of ClpX* at high ATP resembled
the wild-type ClpX at low ATP (Figure 6A). Using DSF, we found
that ClpX* was destabilized in comparison with wild-type ClpX at
high ATP (Figure 6B). As expected, limiting ATP for wild-type
ClpX also resulted in less thermal stability (Figure 6B); ATP binding is known to be needed for ClpX oligomerization (Hersch et al.,
2005). Taken together, these results suggest that under high ATP
concentrations, the mutant ClpX* adopts a set of conformational
states that is overall less stable that wild type.
To gain greater clarity on what structural features might be
different in these states, we performed HDX-MS to determine
specific regions of ClpX and ClpX* that differ in dynamics. We
compared ClpX and ClpX* in high ATP conditions (4 mM) and
found that ClpX* peptides generally showed faster exchange
than the equivalent peptides from wild-type ClpX (Figures 6C,
S6B, and S6C). One of these peptides (residues 186–200) was
the most deprotected in ClpX* compared to ClpX and is buried
in the pore of the closed substrate-bound structure of ClpX
(PDB: 6PO1) (Figures 6C and S6C). Speculation on these results
is discussed below.
DISCUSSION
Because proteolysis is irreversible, the degradation of substrates must be carefully monitored to avoid toxic consequences. In bacteria, different energy-dependent proteases
have distinct substrate preferences that allow them to collectively regulate proteome dynamics. However, how these energy-dependent proteases choose their target substrates from
a pool of cellular proteins remains poorly understood. Certain
determinants that dictate specificity include degrons, or degradation tags, such as the ssrA tag, which marks proteins for
degradation by ClpXP or ClpAP (Keiler, 2015; Keiler et al.,
1996). Specificity can be augmented through adaptor proteins
that help to deliver substrates to proteases. For example, the
degradation of CtrA in Caulobacter is restricted to the ClpXP protease via a highly regulated series of adaptors (Joshi et al., 2015).
In this work, we identified a mutant allele of clpX (clpX*) that
compensates for the loss of Lon through expanding ClpXP
substrate specificity (Figure 6D). The variant ClpX*P protease
complements the growth, motility, replication status, and morphology defects of a Dlon strain (Figures 1A–1C) by restoring
levels and degradation of the Lon substrates DnaA and SciP (Figure 2), which we confirm with biochemical experiments (Figure 3).
Interestingly, ClpX*P has an improved ability to degrade
unfolded protein substrates, a feature that likely explains the
increased proteotoxic tolerance of Dlon clpX* strains (Figure 3).
Cell Reports 40, 111405, September 20, 2022 7
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Figure 5. Limiting ATP alters wild-type ClpXP substrate specificity
(A) Michaelis-Menten plot showing the rate of ClpX/ClpX* catalyzed ATP hydrolysis as a function of ATP concentration. Inset displays kinetic parameters. Assays
were performed with 0.1 mM ClpX6 or ClpX*6, in the presence and absence of 0.2 mM ClpP14. Data were fitted to the Michaelis-Menten equation. Triplicate
experiments are shown. Error bars represent the standard deviation.
(B) FITC-casein degradation by ClpXP or ClpX*P as a function of ATP concentration. Assays were performed with 0.1 mM ClpX6 or ClpX*6, 0.2 mM ClpP14, ATP
regeneration system, and 50 mg/mL FITC-casein. Rates were normalized to highest concentration of ATP. Non-normalized rates shown in the inset. Error bars
represent the standard deviation.
(C) Michaelis-Menten plot showing the rate of degradation as a function of FITC-casein concentration by ClpXP under low and saturating ATP conditions. The
inset displays kinetic parameters. Assays were performed with 0.1 mM ClpX6, 0.2 mM ClpP14, and ATP regeneration system. Data were fitted to the MichaelisMenten equation. Triplicate experiments are shown. Error bars represent the standard deviation.
(D) In vitro degradation of DnaA by ClpXP under low and saturating ATP conditions. Assays were performed with 0.1 mM ClpX6, and 0.2 mM ClpP14 and 0.5 mM
DnaA. Quantification of triplicate experiments.
(E) Antibiotic shutoff assays to monitor DnaA under ATP limiting conditions in WT and Dlon DclpA strains. Chloramphenicol was added to stop synthesis and
lysates from samples at the indicated time points were used for western blot analysis. Quantifications of triplicate experiments shown to the right. Error bars
represent the standard deviation. See also Figure S5.

Finally, this clpX variant is deficient in the proteolysis of normal
ClpXP substrates, such as CtrA and ssrA-tagged proteins, suggesting a shift in substrate preference rather than just an expan-
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sion (Figures 4 and 6D). Mechanistic enzymology revealed that
ClpX* requires approximately five-fold more ATP for the saturation of ATP hydrolysis (Figure 5A), leading us to explore the role
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Figure 6. ClpX adopts distinct ATP-dependent conformational states
(A) Limited proteolysis assay to probe conformational states. ClpX was incubated with chymotrypsin with either 12 mM ATP or 4 mM ATP in the presence of ClpP
and ATP regeneration system at 25 C for the indicated time points. ClpX* was incubated with chymotrypsin at 4 mM ATP in the presence of ClpP and ATP
regeneration system at 25 C for the indicated time points. ClpX was detected using anti-ClpX antibodies.
(B) Stability of ClpX* with 4 mM ATP, ClpX with 4 mM ATP, and ClpX with 12 mM ATP as measured by DSF. Triplicate experiments shown.
(C) Woods plot comparing deuterium uptake for wild-type ClpX vs ClpX* at 4 mM ATP after 60 min. Each bar on the Woods plot represents a single peptide with a
peptide length corresponding with the bar length. Red bars indicate a deprotected (more deuterium uptake) region, blue represents a protected region, and gray
bars are not significantly different. Woods plots were created with Deuteros (Lau et al., 2021) using the peptide significance test (p < 0.01). Residues 186–200 are
highlighted in red for the equivalent residues in the substrate-bound E. coli ClpX structure (PDB: 6PO1) using PYMOL (Schrodinger).
(D) In a wild-type cell, AAA+ proteases Lon and ClpXP promote normal growth by degrading distinct substrates. ClpX*P can compensate for the absence of the
Lon protease by tuning ClpX substrate specificity to better degrade Lon-restricted substrates (such as DnaA, SciP, and misfolded proteins), but this comes at the
cost of native ClpXP substrates (such as ssrA-tagged proteins and CtrA). In ATP-limited conditions, wild-type ClpXP can undergo a similar switch in substrate
specificity to ClpX*P, gaining the ability to better degrade DnaA, SciP, and misfolded proteins than the wild-type enzyme at saturating ATP. See also Figure S6.

of ATP levels in controlling specificity. Surprisingly, our in vitro
studies found that wild-type ClpXP is better at degrading
unfolded proteins, DnaA, and SciP in ATP-limiting conditions,
but worse at degrading ssrA-tagged proteins, similar to the
behavior of ClpX*P even in saturating ATP conditions
(Figures 5B, 5D, 6D, and S5D). In vivo, DnaA degradation by
wild-type ClpXP is accelerated (Figure 5E) in starvation conditions that also deplete ATP. We speculate that the features
that alter ClpX* specificity even in high ATP conditions may
also underlie the same change in specificity seen with wildtype ClpX under low ATP conditions.
How do altered ATP levels or an altered ability to use ATP
change ClpX substrate recognition? One model builds on
emerging cryo-EM structures that have revealed shared features

of substrate-bound AAA+ complexes, namely, a shallow righthanded ring with pore loops gripping the substrate and at least
four ATP-bound protomers (Fei et al., 2020; Gates et al., 2017;
Lopez et al., 2020; Ripstein et al., 2020; Shin et al., 2020). Substrate-free forms of these machines show more open, often
left-handed, spiral structures (Shin et al., 2020; Yokom et al.,
2016). Our limited proteolysis experiments, which show faster
chymotrypsin cleavage kinetics for ClpX* and wild-type ClpX at
low ATP, suggest that they adopt distinct conformations from
wild-type ClpX at saturating ATP (Figure 6A). Using HDX-MS,
we find regions of ClpX* that show faster exchange than wildtype ClpX at saturating ATP (Figures 6C and S6A).
One possible model that arrives from these results is that ClpX
normally samples an open state and a closed state dependent
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on ATP levels. The closed state is the right-handed structure
found in previous ClpXP structures (Fei et al., 2020; Ripstein
et al., 2020), while the open state would be more similar to the
left-handed spiral structures found in substrate-free complexes
(Shin et al., 2020; Yokom et al., 2016). We modeled this open
state for ClpX by aligning six ClpX monomers with the AAA domains of substrate-free Lon from Yersinia pestis (PDB: 6V11;
Shin et al., 2020). The peptide corresponding to residues 186–
200 was no longer buried in this modeled structure, consistent
with a model where ClpX* can more readily adopt an open state
(Figure S6D). In this case, limiting ATP or appropriate mutations
can shift the open/closed balance toward the open state, which
allows ClpX to better capture certain substrates, such as
unfolded proteins, that may not have as strict sequence requirements for recognition (Figure S6E). However, degrons such as
the ssrA tag, which bind selectively to the closed conformation
(Hersch et al., 2005), would be poorly recognized in these conditions (Figure S6E).
Alternatively, the changes in substrate specificity for ClpX* in
saturating ATP conditions and wild-type ClpX under low ATP conditions could be due to entirely distinct mechanisms. For example,
under low ATP concentrations, the ClpX oligomer is likely unstable. As evidence of this, our DSF experiments show additional
destabilization of ClpX in low ATP conditions compared to either
ClpX* and ClpX at saturating ATP (Figure 6B). Similarly, using
HDX-MS, we observed that ClpX in low ATP conditions shows a
faster exchange across the entire sequence of ClpX in comparison with ClpX at high ATP (Figure S6A). The destabilization of
the ClpX hexamer could be underlying the decreased GFP-ssrA
degradation observed upon limiting ATP. However, this model
does not explain why ClpX under limited ATP conditions degrades
FITC-casein, DnaA, and SciP better than at saturating ATP.
Another possibility could be that ATP directly competes with these
substrates for degradation. In this case, intermediate nucleotide
concentrations provide enough ATP to power degradation and
to also relieve inhibition, allowing ClpX to degrade these substrates. However, to date, there is no evidence that nucleotides
directly compete with protein substrates for ClpX.
Prior work has shown that limiting nucleotide leads to loss of
substrate degradation by ClpXP (Martin et al., 2008b), as would
make sense for an ATP-fueled unfoldase. We note that these
studies exclusively used ssrA-tagged substrates, which require
an ATP-bound (closed) form of ClpX for recognition (Martin
et al., 2008a). Thus, the equivalent effects we are seeing here
for casein, DnaA, and SciP would not have been previously
observed, which highlights the importance of using a range of
substrates in understanding activity. In our current work, we speculate that different states of ClpX, favored by either limiting ATP or
mutation, can result in meaningful biological consequences.
Intriguingly, similar conclusions were drawn for the chaperonin
GroEL, where mutants with a shifted specificity that improves
folding of one class of clients at the expense of others also resulted in an altered ATPase cycle attributed to changes in
conformational lifetimes (Wang et al., 2002). Overall, it seems
that exclusive substrate profiles for AAA+ systems are not hardwired but can be altered not only by mutations but also through
modulation of ATP hydrolysis, demonstrating a plasticity in these
machines that yield flexibility in maintaining cellular proteostasis.
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Limitations of the study
While our final model that ATP affects the dynamics of open and
closed states of ClpX oligomers satisfies our biochemical and
cellular results, we acknowledge that there are limitations in
the experimental support of our model. One of the major concerns is that ClpX oligomerization is ATP dependent; therefore,
under reduced ATP conditions the partial dissociation of ClpX
into inactive monomers is a confounding factor in our interpretation of the results. A second concern is that although we favor a
model where ClpX* at saturating ATP mimics wild-type ClpX under limiting ATP in terms of the mechanisms leading to shifted
substrate specificity, it is possible that ClpX* has shifted substrate preference for a reason completely different than why
wild-type ClpX under limiting ATP conditions has a similar shifted
specificity. Because we have not directly measured ATP stoichiometry, we also cannot say for certain whether ClpX or ClpX*
differ in nucleotide occupancy at saturating ATP concentrations.
Finally, although open apo-state spirals and closed substratebound rings have been found for several AAA+ family members
(as described above), these have yet to be directly seen for ClpX.
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BL21DE3 plysS pET23b His6Sumo-CpdR

Lau et al., 2015, Lab collection

EPC196

Top10 pBXMCS-2

Lab collection

EPC407

BL21DE3 plysS pET23b His6SUMO CcrM

Lab collection

EPC 446

BL21DE3 plysS 375 His6-TacA

Joshi et al., 2015, Lab collection

EPC677

BL21DE3 plysS pET23b His6Sumo-RcdA

Joshi et al., 2015, Lab collection

EPC970

TOP10 pET23b His6Sumo-RcdA

Joshi et al., 2015, Lab collection

EPC1000

BL21DE3 plysS pET23b His6Sumo-PopA

Joshi et al., 2015, Lab collection

EPC1037

Delta ClpX W3110 pBAD GFPS65T ccssrA

Lab collection

EPC1508

Top10 pBAD33 His6Sumo DnaA

Lab collection

EPC 1637

BL21DE3 plysS pET23 ClpXG178A

Lab collection

EPC1562

Chemicals, peptides, and recombinant proteins
Mant-ADP triethylammonium salt solution

Sigma-Aldrich

151481-85-5

Mitomycin C

Sigma-Aldrich

M0503

Hydroxyurea

Sigma-Aldrich

H8627

Ez-Tn5 < Kan-2 > transposome

Lucigen

TSM99K2

MasterPure complete gDNA kit

Epicentre

MC85200

Qubit dsDNA HS assay kit

LifeTechnology

Q32851

Critical commercial assays

(Continued on next page)
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Continued
REAGENT or RESOURCE

SOURCE

IDENTIFIER

Nextera XT DNA Library Preparation Kit

Illumina

FC-131-1024

Coomassie Plus (Bradford) Protein Assay

ThermoFisher Scientific

23236

GEO

https://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE166765

F_ClpX*_pNTPS138: GAAGCCGGCTGGCG
CCAAGCTTatgacgaaagccgcgagcggcgacacg

This study

N/A

R_ClpX*_pNTPS138: CGTCACGGCCGAAGC
TAGCGAATTttaggccgaggccgccccaccctttttctcg

This study

N/A

F_ClpX*_pMCS-2: cgcgagacgtccaattg
catatgagaccaccgtgggcccgcgc

This study

N/A

R_ClpX*_pMCS-2: cggtacgcgtaacgttcgaattcT
TAGGCCGAGGCCGCCCCACCCTTTTTC

This study

N/A

pNPTS138_clpX*

This study

N/A

pMCS-2_clpX (merodiploid)

This study

N/A

pMCS-2_clpX* (merodiploid)

This study

N/A

477_eGFP-ssrA(DAS)

This study

N/A

Deposited data
RNA-seq data
Oligonucleotides

Recombinant DNA

Software and algorithms
GraphPadPrism

GraphPad Software

RRID:SCR_002798

R

The R Foundation

RRID:SCR_001905

MicrobeJ

Ducret et al., 2016

https://www.microbej.com/

BWA

Li and Durbin, 2009

http://bio-bwa.sourceforge.net

ImageJ

Schneider et al., 2012

https://fiji.sc/

Samtools

Li et al., 2009

http://www.htslib.org/

BEDTools

Quinlan and Hall, 2010

https://bedtools.readthedocs.
io/en/latest/

Bioconductor

Robinson et al., 2010

https://www.bioconductor.org/

Adobe Illustrator

Adobe

RRID:SCR_010279

DynamX

Waters

N/A

Deuteros

Lau et al., 2021

https://github.com/andymlau/
Deuteros_2.0

PYMOL

Schrödinger

N/A

RESOURCE AVAILABILITY
Lead contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Peter Chien
(pchien@umass.edu).
Materials availability
All unique/stable reagents generated in this study are available from the lead contact without restriction.
Data and code availability
d RNAseq data are available in the NCBI Gene Expression Omnibus (GEO): GSE166765 (https://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE166765).
d This paper does not report original code.
d Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon
request.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Bacterial strains
Bacterial strains used in this study are listed in the key resources table. Caulobacter crescentus strains were grown in PYE medium
(2g/L peptone, 1g/L yeast extract, 1 mM MgSO4, and 0.5 mM CaCl2) at 30 C and supplemented with antibiotics at the following concentrations: kanamycin (25 mg/mL), spectinomycin (100 mg/mL), and oxytetracycline (2 mg/mL). After initial selection steps for strain
construction (excluding plasmids), antibiotics were excluded for all assays.
Escherichia coli strains were grown in LB (10g/L NaCl, 10g/L tryptone, 5g/L yeast extract) and supplemented with antibiotics at the
following concentrations: ampicillin (100 ug/mL), oxytetracycline (15 mg/mL), spectinomycin (50 mg/mL), kanamycin (50 mg/mL), gentamycin (20 mg/mL). For solid medium, 1.5% agar was used regardless of bacterial species. For all strains, optical density was
measured at 600 nm.
For induction purposes, the 477 plasmids were induced with xylose (0.2%) and repressed with glucose (0.2%). For protein expression, 0.4 mM IPTG was used for induction.
METHOD DETAILS
Cloning and strain constructions
All Caulobacter strains were derived from CPC176, an isolate of NA1000. To generate the Dlon clpX* strain, a two-step recombination
protocol with a sucrose counter selection was utilized (Skerker et al., 2005). The vector pNPTS138 was digested with HindIII and
EcoRI. A PCR product of the clpX* sequence was amplified from the original motility suppressor and Gibson assembly was then
used to generate pNPTS138_clpX*. Following transformation with pNPTS138_clpX* into NA1000 or Dlon, primary selection was
on PYE supplemented with kanamycin. Primary colonies were grown overnight without selection and overnight cultures were played
on PYE agar supplemented with 3% w/v sucrose. To validate allelic swap, strains were tested for sensitivity to kanamycin. Dlon clpX*
was also screened by motility and sequencing of the clpX locus validated candidate clones.
ClpX or clpX* merodiploid strains were generated by Gibson assembly of PCR product and double digested plasmids of pMCS-2.
The plasmids were then electroporated into Dlon and selected onto kanamycin plates. Strains were validated by anti-ClpX westerns.
eGFP-ssrA(DAS) induction strains were generated by electroporating eGFP-ssrA(DAS) 477 plasmid into wildtype and wildtype
clpX* and selecting on spectinomycin. Strains were validated by anti-M2 westerns.
Motility suppressor screen
Transposon libraries were generated for Dlon. Two-liter PYE cultures were grown to mid exponential phase, pelleted, and washed
with 10% glycerol. Competent cells were electroporated with Ez-Tn5 <Kan-2> transposome (Lucigen, Madison, WI). Cells recovered
for 90 minutes at 30 C and then played on PYE plates supplemented with kanamycin. Libraries were grown for 7 days. Colonies were
then scraped from the surface, combined, and resuspended to form a homogenous solution of PYE +20% glycerol.
The Tn library was thawed out and diluted into a flask containing two-liter 0.3% agar. The cell agar mixture was plated and grown at
30 C for 3 to 5 days. Candidates that appeared motile were validated by inoculating single colonies into motility agar on the same
plate as NA1000 as a positive control and Dlon as a negative control and incubating plates for 2–3 days at 30 C.
Motility assay
A single colony was inoculated into PYE with 0.3% agar using a sterile pipette tip and left to incubate at 30 C for 2 to 3 days.
Whole genome sequencing
Genomic DNA was extracted using the MasterPure Complete DNA and RNA purification kit (Epicenter Biotechnologies, Madison,
WI). A Qubit Fluorometer (ThermoFisher Scientific, Waltham, MA) was utilized to assess DNA concentration. Illumina libraries
were generated from the extracted genomic DNA using the NexteraXT (Illumina, San Diego, CA) protocol. Libraries were multiplexed
and sequenced at the University of Massachusetts Amherst Genomics Core Facility on the NextSeq 500 (Illumina). Single nucleotide
polymorphisms (SNPs) were detected using breseq (Deatherage and Barrick, 2014).
RNA sequencing
RNA was extracted from stationary phase cells. Libraries were generated from the extracted RNA using the NEB Next RNA Library
Prep kits (NEB, Ipswich, MA). Libraries were sequenced at the University of Massachusetts Genomics Core Facility on the NextSeq
500 with single end 75 base reads.
Plating viability and drug sensitivity
All Caulobacter strains were grown overnight in liquid PYE media. After overnight growth, cells were back diluted to OD600 0.1 and
outgrown to mid-exponential phase before being normalized to OD600 0.1 and 10-fold serially diluted on to media. For experiments
using mitomycin C (Sigma, St. Louis, MO) and L-canavanine (Sigma), drugs were prepared at a stock concentration of 400 mg/mL
mitomycin C, and 100 mg/ml L-canavanine and filter sterilized. PYE agar was cooled before the drugs were added and plates
were left to air dry prior to serial dilution plating. All plates were incubated at 30 C for 2–3 days and imaged with a Syngene G:Box.
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In vivo assays
The stability of proteins in vivo was determined by inhibiting protein synthesis upon addition of 30 mg/mL chloramphenicol to cells
in exponential phase. At each time point, 1mL of culture was removed and centrifuged at 15,000 rpm for 2 minutes. The supernatant was removed and pellets were flash frozen in liquid nitrogen. Pellets were thawed, resuspended in 2x SDS dye, and normalized to the OD600 of the lowest sample. Samples were boiled for 10 minutes and centrifuged for 10 minutes at 15,000 rpm. Extracts were run on 10% Bis-Tris gels for 1 hour at room temperature at 150 V. Gels were then transferred to nitrocellulose
membranes for 1 hour at room temperature at 20V. Membranes were blocked with 3% milk in Tris-based saline with 0.05%
Tween-20 (TBST) for 1 hour. Membranes were probed with primary antibody in 3% milk in TBST at 4 C overnight with following
dilution factors: 1:5000 dilution of DnaA, 1:5000 SciP, 1:5000 CcrM, 1:5000 ClpP, 1:2500 Lon, and 1:2000 M2. Membranes were
washed with 1x TBST for 5 minutes three times and then probed with Licor secondary antibody with 1:10,000 dilution in 1x TBST
at room temperature for 1 hour.
To synchronize Caulobacter strains, cells were grown to an OD600 of 0.3–0.5 in PYE and swarmer cells were isolated using Percoll
density centrifugation. Cells were released into PYE.
Flow cytometry was used to measure DNA content in rifampicin-treated cells as previously described (Chen et al., 2009). Cells
were treated with rifampicin for three hours prior to fixing in 70% ethanol.
Carbon starvation
Cells were grown in M2G media (6.1 mM Na2HPO4, 3.9 mM KH2PO4, 9.3 mM NH4Cl, 0.5 mM MgSO4, 0.5 mM CaCl2, 10 mM FeSO4
(EDTA chelate), 0.2% glucose). Cells were then washed twice in cold M2G media (+glucose samples) or in M2 media (-glucose samples) and resuspended in pre-warmed M2G or M2 media.
Growth competition assay
Overnight cultures of CPC798 were mixed with either NA1000 or clpX* at a 1:1 ratio. For competition assays with Dlon strains, overnight cultures of CPC807 were mixed with either Dlon or Dlon clpX* at a 1:1 ratio. Mixed strains were diluted into fresh PYE and
allowed to outgrow for 12 doublings overnight. The initial populations were verified by phase contrast and fluorescent microscopy.
Final ratios were normalized to their starting ratios. Data was plotted using GraphPad Prism.
Microscopy
Phase contrast images of logarithmically growing cells were taken by Zeiss AXIO Scope A1. Cells were mounted on 1% PYE agar
pads and imaged using a 100X objective. Representative images of the same scale were cropped to display morphological defects.
Protein purification and modification
Untagged Lon, untagged ClpX and ClpX*, and his-tagged ClpP were purified as previously described (Chien et al., 2007; Goldberg
et al., 1994; Gur and Sauer, 2008; Levchenko et al., 2000). Titin-I27-b20 was purified as previously described (Gur and Sauer, 2008;
Kenniston et al., 2003) and labeled with Fluorescein-5-maleimide (Thermo Scientific) under guanidine hydrochloride denaturation.
The modified protein was buffer exchanged into H-buffer (20 mM Hepes pH 7.5, 100 mM KCl, 10 mM MgCl2, 10% glycerol) and
stored at 4 C. The concentration of fluorescein-modified Titin-I27-b20 was determined using the Bradford assay (Thermo Scientific).
FITC-Casein (Type III, Sigma) was prepared in water and stored at 20 C. His6SciP and his6CtrA were purified as described in (Gora
et al., 2013). DnaA and CcrM were purified as his6SUMO tagged proteins, followed by tag cleavage as described (Jonas et al., 2013;
Liu et al., 2016; Wang et al., 2007). GFP-ssrA was purified as previously described (Yakhnin et al., 1998). CtrA-RD+15 was purified as
described (Smith et al., 2014). Detailed purification protocols are available upon request.
In vitro reconstitution assays
Degradation assays were performed at 30 C and monitored using SDS-PAGE gels as described previously (Bhat et al., 2013). The
final concentrations used can be found in the figure legends.
Limited proteolysis
To perform limited chymotrypsin digestion, 0.004 mg/mL chymotrypsin was added to 0.01 mg/mL ClpX or ClpX* in the presence of
ClpP and ATP regeneration system and incubated at 25 C in Hepes buffer (20 mM Hepes pH 7.5, 100 mM KCl, 10 mM MgCl2,
10% glycerol) for indicated time points. To quench the reactions, 5X SDS dye supplemented with 5 mM Protease inhibitor phenylmethylsulfonyl fluoride (PMSF) was added. The samples were run on a 10% Bis-Tris gel and transferred to nitrocellulose as
described above. Membranes were probed with primary antibody in 3% milk in TBST at 4 C overnight with following dilution
factors: 1:5000 dilution of ClpX. Membranes were washed with 1x TBST for 5 minutes three times and then probed with Licor
secondary antibody with 1:10,000 dilution in 1x TBST at room temperature for 1 hour. The protein was visualized using Licor
Odyssey CLx.
Binding of ADP to ClpX
625 nM mant-ADP was pre-incubated with 300 nM ClpX6/ClpX6* for 10 minutes. Subsequently, ATPgS was added to compete off the
mant-ADP at various concentrations. Polarization measurements were read from 20 uL of these mixtures after an additional
15-minute incubation using opaque black NBS 384-well plates (Corning) and a SpectraMax M5 plate reader (Molecular Devices),
with excitation and emission wavelengths set at 357 and 445 nm, respectively.
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Differential scanning fluorimetry
Differential scanning fluorimetry was carried out in a Biorad realtime PCR thermocycler. 6 mM monomer of ClpX or ClpX* in the presence of 4 mM ATP or 12 mM ATP was mixed in a 1:1 ratio with 4X Sypro Orange in Hepes Buffer (20 mM Hepes pH 7.5, 100 mM KCl,
10 mM MgCl2). The resulting mixtures were incubated at room temperature for 30 mins to allow the Sypro Orange to coat the proteins
before subjecting triplicate samples to thermal unfolding from 25 C to 95 C. Melting temperatures were calculated by fitting of a
5-parameter sigmoid curve using the JTSA software (P. Bond, https://paulsbond.co.uk/jtsa).
Hydrogen-deuterium exchange mass spectrometry (HDX-MS) Hydrogen-deuterium exchange experiments were carried out on a
Synapt G2Si high-definition mass spectrometer (Waters) using an automated HDX robotics platform (Waters). Samples of 5.4 mM
ClpX or ClpX* monomer were diluted 1:16 in D2O buffer containing 20 mM Hepes, 10 mM MgCl2, 100 mM KCl, and 5% glycerol.
D2O and H2O buffers were supplemented with 4 mM ATP plus regeneration system (30 mM creatine kinase and 0.5 mg/mL creatine
phosphate) for the high ATP condition and 12 mM ATP for the low ATP condition. Deuterium exchange was allowed to take place for 0,
10 seconds, 1 min, 10 minutes, and 60 min at 25 C. The samples were subsequently quenched by addition of cold quench buffer
(233 mM Sodium Phosphate pH 2.5) and run over an immobilized Waters ENZYMATE immobilized pepsin column (inner diameter:
2.1 3 30 mm) at a flow rate of 0.15 mL/min at high pressure (11,000 psi) for peptide digestion. Blank runs were run in between each
analysis to avoid peptide carry over. Continuous lock-mass correction was performed using leu-enkephalin compound. Peptides
were ionized and separated by electrospray ionization for analysis at a mass resolution of 50 to 2,000 m/z range. Peptides were identified with triplicate undeuterated samples from each condition. Specific peptide regions were mapped onto the corresponding residues in the E. coli cryo-EM structure (PDB ID: 6PO1) using PYMOL (Version 2.5.0, Schrödinger). A model of ClpX in the potential open
state was created by aligning each ClpX monomer to each ATPase monomer of the Y. pestis substrate-free cryo-EM structure (PDB
ID: 6V11) by using the align function in PYMOL.
QUANTIFICATION AND STATISTICAL ANALYSIS
Graphs were generated in GraphPad Prism. Unless otherwise stated in the figure legend, results represent the mean ± Standard Deviation (SD). Sample sizes are also reported in the figure notes. Error bars for the growth curves shown in Figure 1A represent the 95%
confidence interval.
RNA sequencing data
Reads were mapped to the Caulobacter genome using BWA (Li and Durbin, 2009) and sorted with Samtools (Li et al., 2009).To obtain
the number of reads per gene, bedtools map (Quinlan and Hall, 2010) was used. Rstudio and EdgeR was used to identify differentially
expressed genes (R Core Team, 2019; Robinson et al., 2010).
Raw counts were normalized using the counts-per-million (CPM) method, and the edgeR package in R was used to perform differential gene expression analysis, KEGG pathway analysis, and FRY (Wu et al., 2010) gene set analysis. We filtered out any gene that
had less than 30 normalized counts across 3 or more samples. To test for gene expression differences and identify differentially
expressed genes across experimental groups, we used the quasi-likelihood F-test. The over-representation analysis for KEGG pathways done using the kegga function. FRY gene set analysis done using the fry function. The CcrM, DnaA, and SciP regulons were
obtained from (Gonzalez et al., 2014; Hottes et al., 2005; Tan et al., 2010).
In vivo assays
For western blots, proteins were visualized using Licor Odyssey CLx. Bands were quantified using ImageJ (NIH) and degradation
rates were plotted using Prism (Graphpad).
For bulk measurements of intracellular ATP, the Bactiter-Glo microbial cell viability assay kit (Promega) was used. Cells were mixed
with an equal volume of BacTiter-Glo reagent in 384-well microtiter plates and incubated for five minutes before luminescence was
measured.
For microscopy, MicrobeJ (Ducret et al., 2016) for ImageJ (Schneider et al., 2012) was utilized to quantify cell lengths. Stalk lengths
were quantified using ImageJ. Prism was utilized for representations of cell and stalk length measurements.
In vitro assays
Densitometry for degradation assays was performed with ImageJ and degradation rates were plotted using Prism.
Degradation of FITC-Casein and FT-Titin-B20 was monitored as an increase in fluorescence over time. GFP-CtrARD+15 degradation was observed as a loss of fluorescence over time as described previously (Smith et al., 2014).
ATP hydrolysis for ClpXP and ClpX*P was measured using a coupled kinase assay as previously described (Burton et al., 2003).
For binding of ADP to ClpX, IC50s were calculated by fitting the polarization data using GraphPad Prism to an inhibitor versus
response – variable slope (four paramaters) function in GraphPad Prism: Y = Bottom + (Top-Bottom)/(1+(IC50/X)^HillSlope) where
IC50 is the ATPgS concentration halfway between bottom and top.
For differential scanning fluorimetry, melting temperatures were calculated by fitting of a 5-parameter sigmoid curve using the
JTSA software (P. Bond, https://paulsbond.co.uk/jtsa).
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HDX-MS data
HDX-MS experiments were performed in triplicate. Identification of peptides and analysis of the uptake plots and charge states for
each peptide were completed in Protein Lynx Global Server and DynamX (v. 3.0, Waters). The following processing paramaters were
utilized: minimum peptide intensity of 1000, minimum peptide length of 5, maximum peptide length of 30, minimum MS/MS products
of 2, minimum products per amino acid of 0.25, minimum score of 5, and maximum MH+ error threshold of 15 p.p.m. Woods plots
were generated by Deuteros (Lau et al., 2021) using the peptide significance test (p-value <0.01). HDX data summary for each condition was exported from Deuteros and can be found in Data S2. No correction was made for back-exchange.
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